集体诉讼案件背景 - 律师事务所Levi & Korsinsky针对Snap Inc提起证券集体诉讼 涉及期间为2025年4月29日至8月5日 [1] - 诉讼指控公司在此期间存在证券欺诈行为 导致投资者遭受损失 [1] 财务表现指控 - 公司被指控在广告收入增长率方面发布重大虚假和误导性陈述 实际增长率从第一季度的9%大幅下降至4月的1% [2] - 2025年8月5日公司公布第二季度财务业绩 承认广告收入增长减速 并将原因归咎于广告平台问题、斋月时间安排及微小变化影响 [2] 股价影响 - 财报发布后公司股价从2025年8月5日收盘价9.39美元/股暴跌至8月6日7.78美元/股 单日跌幅达17.15% [2] 诉讼程序安排 - 受影响投资者可在2025年10月20日前申请作为首席原告参与诉讼 [3] - 集体诉讼成员可能无需支付自付费用即可获得补偿 [3] 律师事务所资质 - Levi & Korsinsky过去20年为受损股东追回数亿美元资金 拥有70多名员工的专业团队 [4] - 该律所连续七年被ISS证券集体诉讼服务评为美国前50大证券诉讼公司之一 [4]

Accessibility StatementSkip Navigation NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and b ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in KinderCare Learning Companies, Inc. ("KinderCare Learning Companies, Inc." or the "Company") (NYSE: KLC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KinderCare Learning Companies, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of KinderCare common stock in o ...

诉讼背景 - 律师事务所Levi & Korsinsky代表Lineage Inc (NASDAQ: LINE)投资者提起集体诉讼 指控公司涉嫌证券欺诈[1][2] - 诉讼针对2024年7月26日IPO时通过注册声明购买公司普通股的投资者[2] 指控内容 - 公司隐瞒客户需求持续疲软 因新增冷库供应上线 COVID-19疫情期间积累的过剩库存被清空 客户转向维持更精简的冷库库存[3] - 公司在IPO前实施的涨价在需求疲软环境下不可持续[3] - 公司无法通过最低存储保证、运营效率、技术改进或竞争优势抵消不利趋势[3] - 公司实际面临收入停滞或下降、占用率和租金价格下跌 与注册声明中稳定的收入增长、高占用率和稳定租金增长的表述不符[3] - 公司财务状况、业务运营和前景因此受到重大损害[3] 诉讼程序 - 投资者可在2025年9月30日前申请作为首席原告[4] - 集体成员可能无需支付自付费用即可获得补偿[4]

Accessibility StatementSkip Navigation https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=167315&wire=4 SVRA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) MOLBREEVI BLA, the treatment of pulmonary alveolar proteinosis, lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (ii) a ...

Accessibility StatementSkip Navigation CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Dow's ability to mitigate macroeconomic and tariff-related headwinds, as well as to maintain the financial flexibility needed to support its lucrative dividend, was overstated; (ii) the true scope and severity of the foregoing headwinds' negative impacts on Dow's business and financial condition was understated, particularly with respect to competitive and pricing ...

Accessibility StatementSkip Navigation https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=167310&wire=4 NUTX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) HaloMD, a third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii ...

Sep 16, 2025 7:10 AM Eastern Daylight Time If you suffered substantial losses and wish to serve as lead plaintiff of the V.F. Corporation class action lawsuit, please provide your information here: https://www.rgrdlaw.com/cases-v-f-corporation-class-action-lawsuit-vfc.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449- 4900 or via e-mail at info@rgrdlaw.com. CASE ALLEGATIONS: V.F. Corporation, together with its subsidiaries, offers branded apparel, ...

SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- The law firm ofRobbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of V.F. Corporation. (NYSE: VFC) securities between October 30, 2023 and May 20, 2025, inclusive (the "Class Period"), have until November 12, 2025 to seek appointment as lead plaintiff of the V.F. Corporation class action lawsuit. Captioned Brenton v. V.F. Corporation, No. 25-cv-02878 (D. Colo.), the V.F. Corporation class action lawsuit charges V.F. Corporation and certain of V. ...

诉讼事件概述 - 罗森律师事务所代表在2023年10月30日至2025年5月20日期间购买V F Corporation证券的投资者提起集体诉讼 [1] - 诉讼指控被告传播重大虚假和误导性陈述和/或隐瞒重大不利事实 涉及V F Corporation转型计划的真实状况 [5] 诉讼核心指控 - 被告向投资者提供有关V F Corporation转型计划（"Reinvent"）的重大信息 该计划部分侧重于让Vans品牌恢复正增长 [5] - 据称被告隐瞒了需要额外的重大重置行动才能使Vans品牌恢复增长 这将导致Vans收入增长轨迹出现重大挫折 [5] - 当真实细节进入市场时 投资者遭受了损失 [5] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼 在全球代表投资者 [4] - 该事务所在2017年因证券集体诉讼和解数量被ISS证券集体诉讼服务公司排名第一 自2013年以来每年排名前四 [4] - 该事务所已为投资者追回数亿美元 仅在2019年就为投资者获得了超过4.38亿美元 [4] - 该事务所曾达成当时针对中国公司的有史以来最大的证券集体诉讼和解 [4] 参与程序信息 - 投资者可在2025年11月12日前向法院申请担任首席原告 [1][3] - 投资者可通过指定网站或电话联系Phillip Kim律师参与集体诉讼 [3][6] - 在类别被认证之前 投资者不被律师代表 除非自己聘请律师 [7] - 投资者分享任何潜在未来回收资金的能力不取决于担任首席原告 [7]